MedBright AI to Rebrand as GoGo AI Network, Changing CSE Ticker to GOGO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 29 2025
0mins
Source: Newsfilter
- Company Rebranding: MedBright AI Investments Inc. intends to change its name to GoGo AI Network Inc., with an effective date of January 5, 2026, reflecting the company's strategic shift towards artificial intelligence and global expansion.
- Investment Policy Update: The company has filed an amended investment policy focusing on early-stage and growth-stage AI technology investments, which is expected to enhance investment flexibility and risk management capabilities, thereby strengthening its competitive position in the rapidly evolving AI market.
- Diverse Investment Structures: The new policy allows the company to utilize various investment structures, including equity, debt, and convertible instruments, aiming to achieve higher commercial scalability and return potential through a diversified portfolio.
- Clear Strategic Objectives: The amended investment policy provides clearer investment objectives and management practices, which are anticipated to help the company more effectively identify and seize high-growth investment opportunities in future transactions.
Analyst Views on MBAI
About MBAI
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
